Author: Donald W. Light
Publisher: Springer
ISBN: 1137374330
Category : Social Science
Languages : en
Pages : 278
Book Description
Drawing on key concepts in sociology and management, this history describes a remarkable institute that has elevated medical research and worked out solutions to the troubling practices of commercial pharmaceutical research. Good Pharma is the answer to Goldacre's Bad Pharma: ethical research without commercial distortions.
Good Pharma
Author: Donald W. Light
Publisher: Springer
ISBN: 1137374330
Category : Social Science
Languages : en
Pages : 278
Book Description
Drawing on key concepts in sociology and management, this history describes a remarkable institute that has elevated medical research and worked out solutions to the troubling practices of commercial pharmaceutical research. Good Pharma is the answer to Goldacre's Bad Pharma: ethical research without commercial distortions.
Publisher: Springer
ISBN: 1137374330
Category : Social Science
Languages : en
Pages : 278
Book Description
Drawing on key concepts in sociology and management, this history describes a remarkable institute that has elevated medical research and worked out solutions to the troubling practices of commercial pharmaceutical research. Good Pharma is the answer to Goldacre's Bad Pharma: ethical research without commercial distortions.
Good Pharma
Author: Donald W. Light
Publisher: Springer
ISBN: 1137374330
Category : Social Science
Languages : en
Pages : 289
Book Description
Drawing on key concepts in sociology and management, this history describes a remarkable institute that has elevated medical research and worked out solutions to the troubling practices of commercial pharmaceutical research. Good Pharma is the answer to Goldacre's Bad Pharma: ethical research without commercial distortions.
Publisher: Springer
ISBN: 1137374330
Category : Social Science
Languages : en
Pages : 289
Book Description
Drawing on key concepts in sociology and management, this history describes a remarkable institute that has elevated medical research and worked out solutions to the troubling practices of commercial pharmaceutical research. Good Pharma is the answer to Goldacre's Bad Pharma: ethical research without commercial distortions.
Bad Pharma
Author: Ben Goldacre
Publisher: Macmillan
ISBN: 0865478066
Category : Business & Economics
Languages : en
Pages : 479
Book Description
Originally published in 2012, revised edition published in 2013, by Fourth Estate, Great Britain; Published in the United States in 2012, revised edition also, by Faber and Faber, Inc.
Publisher: Macmillan
ISBN: 0865478066
Category : Business & Economics
Languages : en
Pages : 479
Book Description
Originally published in 2012, revised edition published in 2013, by Fourth Estate, Great Britain; Published in the United States in 2012, revised edition also, by Faber and Faber, Inc.
Pharma
Author: Gerald Posner
Publisher: Simon and Schuster
ISBN: 1501152033
Category : Business & Economics
Languages : en
Pages : 816
Book Description
"Exorbitant prices for lifesaving drugs, safety recalls affecting tens of millions of Americans, and soaring rates of addiction and overdose on prescription opioids have caused many to lose faith in pharmaceutical companies. Now, Americans are demanding national reckoning with a monolithic industry. In Pharma, award-winning journalist and New York Times best-selling author Gerald Posner uncovers the real story of the Sacklers, the family that became one of America's wealthiest from the success of OxyContin, their blockbuster narcotic painkiller at the centure of the opioid crisis. The unexpected twists and turns of the Sakler family saga are told against the startling chronicle of a powerful industry that sits at the intersection of public health and profits. Pharma reveals how and why American drug companies have put earnings ahead of patients"--
Publisher: Simon and Schuster
ISBN: 1501152033
Category : Business & Economics
Languages : en
Pages : 816
Book Description
"Exorbitant prices for lifesaving drugs, safety recalls affecting tens of millions of Americans, and soaring rates of addiction and overdose on prescription opioids have caused many to lose faith in pharmaceutical companies. Now, Americans are demanding national reckoning with a monolithic industry. In Pharma, award-winning journalist and New York Times best-selling author Gerald Posner uncovers the real story of the Sacklers, the family that became one of America's wealthiest from the success of OxyContin, their blockbuster narcotic painkiller at the centure of the opioid crisis. The unexpected twists and turns of the Sakler family saga are told against the startling chronicle of a powerful industry that sits at the intersection of public health and profits. Pharma reveals how and why American drug companies have put earnings ahead of patients"--
Saving Talk Therapy
Author: Enrico Gnaulati
Publisher: Beacon Press
ISBN: 0807093416
Category : Psychology
Languages : en
Pages : 266
Book Description
A hard-hitting critique of how managed care and the selective use of science to privilege quick-fix therapies have undermined in-depth psychotherapy—to the detriment of patients and practitioners In recent decades there has been a decline in the quality and availability of psychotherapy in America that has gone largely unnoticed—even though rates of anxiety, depression, and suicide are on the rise. In Saving Talk Therapy, master therapist Dr. Enrico Gnaulati presents powerful case studies from his practice to remind patients and therapists alike how and why traditional talk therapy works and, using cutting-edge research findings, unpacks the problematic incentives in our health-care system and in academic psychology that explain its decline. Beginning with a discussion of the historical development of talk therapy, Dr. Gnaulati goes on to dissect the factors that have undermined it. Psychotropic drugs, if no longer thought of as a magical cure, are still over-prescribed and shunt health-care dollars to drug corporations. Managed-care companies and mental health “carve outs” send health-care dollars to administrators, drive many practitioners away, and over-burden those who remain. And drawing back the curtains on CBT (cognitive behavior therapy), Dr. Gnaulati shows that while it might be effective in the research lab, its findings are of limited use for the people’s complex, real-world emotional problems. Saving Talk Therapy is a passionate and deeply researched case for in-depth, personally transformative psychotherapy that incorporates the benefits of an evidence-based approach and psychotropic drugs without over-relying on them.
Publisher: Beacon Press
ISBN: 0807093416
Category : Psychology
Languages : en
Pages : 266
Book Description
A hard-hitting critique of how managed care and the selective use of science to privilege quick-fix therapies have undermined in-depth psychotherapy—to the detriment of patients and practitioners In recent decades there has been a decline in the quality and availability of psychotherapy in America that has gone largely unnoticed—even though rates of anxiety, depression, and suicide are on the rise. In Saving Talk Therapy, master therapist Dr. Enrico Gnaulati presents powerful case studies from his practice to remind patients and therapists alike how and why traditional talk therapy works and, using cutting-edge research findings, unpacks the problematic incentives in our health-care system and in academic psychology that explain its decline. Beginning with a discussion of the historical development of talk therapy, Dr. Gnaulati goes on to dissect the factors that have undermined it. Psychotropic drugs, if no longer thought of as a magical cure, are still over-prescribed and shunt health-care dollars to drug corporations. Managed-care companies and mental health “carve outs” send health-care dollars to administrators, drive many practitioners away, and over-burden those who remain. And drawing back the curtains on CBT (cognitive behavior therapy), Dr. Gnaulati shows that while it might be effective in the research lab, its findings are of limited use for the people’s complex, real-world emotional problems. Saving Talk Therapy is a passionate and deeply researched case for in-depth, personally transformative psychotherapy that incorporates the benefits of an evidence-based approach and psychotropic drugs without over-relying on them.
Pharmacy
Author: William N. Kelly
Publisher: CRC Press
ISBN: 9780849372469
Category : Medical
Languages : en
Pages : 524
Book Description
The health care and pharmacy environments have changed substantially since the first edition of this book. Developments include the new Medicare prescription benefit, a growing emphasis on medication safety, and the dynamic technology driving safety in organized health care settings. Exploring these recent modifications, Pharmacy: What It Is and How It Works, Second Edition encompasses all aspects of pharmacy, from the various roles of pharmacists to particular health care-related events to career-planning information. The book first focuses on the core of pharmacy, providing an overview of the field and a chapter dedicated to pharmacists. After an examination of how drug products are developed, used, and priced, it discusses the important topics of pharmacy technicians, information technology, pharmacy automation, and pharmaceutical care. Subsequent chapters cover the various areas where pharmacists work, including in community, hospital, home health care, and government pharmacies. The book concludes with chapters on the pharmaceutical industry and career planning. Each chapter features learning objectives, summaries, discussion questions, exercises, Web sites of interest, and references. Pharmacies have evolved from the corner drugstores of old. To help navigate the modern field of pharmacy, this text provides a well-written, organized introduction for new pharmacy students, pharmacy technician trainees, and practitioners.
Publisher: CRC Press
ISBN: 9780849372469
Category : Medical
Languages : en
Pages : 524
Book Description
The health care and pharmacy environments have changed substantially since the first edition of this book. Developments include the new Medicare prescription benefit, a growing emphasis on medication safety, and the dynamic technology driving safety in organized health care settings. Exploring these recent modifications, Pharmacy: What It Is and How It Works, Second Edition encompasses all aspects of pharmacy, from the various roles of pharmacists to particular health care-related events to career-planning information. The book first focuses on the core of pharmacy, providing an overview of the field and a chapter dedicated to pharmacists. After an examination of how drug products are developed, used, and priced, it discusses the important topics of pharmacy technicians, information technology, pharmacy automation, and pharmaceutical care. Subsequent chapters cover the various areas where pharmacists work, including in community, hospital, home health care, and government pharmacies. The book concludes with chapters on the pharmaceutical industry and career planning. Each chapter features learning objectives, summaries, discussion questions, exercises, Web sites of interest, and references. Pharmacies have evolved from the corner drugstores of old. To help navigate the modern field of pharmacy, this text provides a well-written, organized introduction for new pharmacy students, pharmacy technician trainees, and practitioners.
Getting to Good
Author: Arthur L. Caplan
Publisher: Springer
ISBN: 3319513583
Category : Medical
Languages : en
Pages : 585
Book Description
This book represents the first comprehensive, gold standard reader on research integrity in the biomedical sciences. Now more than ever, the responsible conduct of research (RCR) has become critically important as new technologies affect research practices in both positive and negative ways. Since learning to do science and practicing it brings researchers into contact with a vast array of ethical issues, it is critical to know the standards and how they are evolving. Indeed, research integrity requires scientists at all levels to operate ethically in a system that supports ethical practice. This unique, foundational text covers all the relevant areas -- subject protection, research misconduct and conflict of interest as well as newly quantified concerns about research bias and non-reproducibility, as well as other unique issues. Developed by renowned experts, this compelling title discusses the full range of practices and policies that should support research that is honestly produced and disseminated. It also specifically incorporates topics noted by the National Institutes of Health as essential and required for training in RCR. Getting to Good – Research Integrity in the Biomedical Sciences is a major contribution to the literature on bioethics and will serve as an invaluable resource for all researchers, students, administrators and professionals interested in research ethics and integrity.
Publisher: Springer
ISBN: 3319513583
Category : Medical
Languages : en
Pages : 585
Book Description
This book represents the first comprehensive, gold standard reader on research integrity in the biomedical sciences. Now more than ever, the responsible conduct of research (RCR) has become critically important as new technologies affect research practices in both positive and negative ways. Since learning to do science and practicing it brings researchers into contact with a vast array of ethical issues, it is critical to know the standards and how they are evolving. Indeed, research integrity requires scientists at all levels to operate ethically in a system that supports ethical practice. This unique, foundational text covers all the relevant areas -- subject protection, research misconduct and conflict of interest as well as newly quantified concerns about research bias and non-reproducibility, as well as other unique issues. Developed by renowned experts, this compelling title discusses the full range of practices and policies that should support research that is honestly produced and disseminated. It also specifically incorporates topics noted by the National Institutes of Health as essential and required for training in RCR. Getting to Good – Research Integrity in the Biomedical Sciences is a major contribution to the literature on bioethics and will serve as an invaluable resource for all researchers, students, administrators and professionals interested in research ethics and integrity.
The Good Pharmacist
Author: William N. Kelly
Publisher:
ISBN: 9780615393216
Category : Pharmaceutical services
Languages : en
Pages : 135
Book Description
This book is based on a study of what pharmacists, physicians, nurses, and patients think are the qualities of the "good pharmacist. It is intended for pharmacists, student pharmacists, and those who manage pharmacists.
Publisher:
ISBN: 9780615393216
Category : Pharmaceutical services
Languages : en
Pages : 135
Book Description
This book is based on a study of what pharmacists, physicians, nurses, and patients think are the qualities of the "good pharmacist. It is intended for pharmacists, student pharmacists, and those who manage pharmacists.
The Finder
Author: Colin Harrison
Publisher: Macmillan
ISBN: 9780374299491
Category : Fiction
Languages : en
Pages : 348
Book Description
Jin-Li, a secretive Chinese woman who becomes involved in a plot to steal valuable information from corporations in New York City, is forced to go on the run when her complicity is discovered by powerful New Yorkers who stand to lose a fortune.
Publisher: Macmillan
ISBN: 9780374299491
Category : Fiction
Languages : en
Pages : 348
Book Description
Jin-Li, a secretive Chinese woman who becomes involved in a plot to steal valuable information from corporations in New York City, is forced to go on the run when her complicity is discovered by powerful New Yorkers who stand to lose a fortune.
The Antidote
Author: Barry Werth
Publisher: Simon and Schuster
ISBN: 1451655665
Category : Business & Economics
Languages : en
Pages : 448
Book Description
In 1989, the charismatic Joshua Boger left Merck, then America's most admired business, to found a drug company that would challenge industry giants and transform health care. Journalist Barry Werth described the company's tumultuous early days during the AIDS crisis in The Billion-Dollar Molecule, a celebrated classic of science and business journalism. Now he returns to tell the story of Vertex's bold endurance and eventual success. The pharmaceutical business is America's toughest and one of its most profitable. It's riskier and more rigorous at just about every stage than any other business, from the towering biological uncertainties inherent in its mission to treat disease; to the 30-to-1 failure rate in bringing out a successful medicine; to the multibillion-dollar cost of ramping up a successful product; to operating in the world's most regulated industry, matched only by nuclear power. Werth captures the full scope of Vertex's 25-year drive to deliver breakthrough medicines.--From publisher description.
Publisher: Simon and Schuster
ISBN: 1451655665
Category : Business & Economics
Languages : en
Pages : 448
Book Description
In 1989, the charismatic Joshua Boger left Merck, then America's most admired business, to found a drug company that would challenge industry giants and transform health care. Journalist Barry Werth described the company's tumultuous early days during the AIDS crisis in The Billion-Dollar Molecule, a celebrated classic of science and business journalism. Now he returns to tell the story of Vertex's bold endurance and eventual success. The pharmaceutical business is America's toughest and one of its most profitable. It's riskier and more rigorous at just about every stage than any other business, from the towering biological uncertainties inherent in its mission to treat disease; to the 30-to-1 failure rate in bringing out a successful medicine; to the multibillion-dollar cost of ramping up a successful product; to operating in the world's most regulated industry, matched only by nuclear power. Werth captures the full scope of Vertex's 25-year drive to deliver breakthrough medicines.--From publisher description.